Vincenzo D'Alonzo

5PUBLICATIONS
25CO-AUTHORS
Medical mycologyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 07, 2026
Circulating EV-microRNAs are dynamic biomarkers of resistance to therapeutic immunomodulation in metastatic melanoma.

|Apr 27, 2026
Tumor DNA methylation subtypes predict immunotherapy outcomes in pleural mesothelioma patients in the NIBIT-EPI-MESO study.

|Feb 13, 2026
A Real-World Experience of Cemiplimab in Patients with Advanced Cutaneous Squamous Cell Carcinoma.

Matteo Ravara, Tommaso Sani, Vincenzo D'Alonzo

|Jul 29, 2025
Biomolecular Predictors of Recurrence Patterns and Survival in IDH-Wild-Type Glioblastoma: A Retrospective Analysis of Patients Treated with Radiotherapy and Temozolomide.

Paolo Tini, Flavio Donnini, Francesco Marampon

|Dec 02, 2022
Successful Targeting of CTLA-4 in a Melanoma Clinical Case: A Long-Term "One Stop Therapeutic Shop".

Maura Colucci, Vincenzo D'Alonzo, Federica Santangelo

Pageof 1

Frequent Collaborators

2 joint publications

Michele Ceccarelli

2 joint publications

Anna Maria Di Giacomo

1 joint publications

Maura Colucci

1 joint publications

Alfonso Cerase